Integrase Inhibitors Use for HIV Infection in Pregnancy

被引：0
|
作者：
Sávio Amaral
Carlos Brites
Eduardo Sprinz
机构：
[1] Programa de Pós-Graduação Em Medicina E Saúde (PPgMS),Laboratório de Pesquisa Em Infectologia (LAPI)
[2] Universidade Federal da Bahia,Faculdade de Medicina
[3] Hospital Universitário Prof. Edgard Santos (HUPES),undefined
[4] Universidade Federal da Bahia,undefined
[5] Hospital de Clínicas de Porto Alegre,undefined
[6] Universidade Federal Do Rio Grande Do Sul,undefined
来源：
Current Infectious Disease Reports | 2022年 / 24卷
关键词：
HIV; Pregnant women; Integrase inhibitors; Mother-to-child transmission; Dolutegravir; Raltegravir;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：9 / 19
页数：10
相关论文
共 50 条
  • [31] Beyond the effects of HIV infection and integrase inhibitors-based therapies on oral bacteriome
    Pablo Villoslada-Blanco
    Patricia Pérez-Matute
    Emma Recio-Fernández
    María Íñiguez
    Pilar Blanco-Navarrete
    Luis Metola
    Valvanera Ibarra
    Jorge Alba
    María de Toro
    José A. Oteo
    Scientific Reports, 13
  • [32] Beyond the effects of HIV infection and integrase inhibitors-based therapies on oral bacteriome
    Villoslada-Blanco, Pablo
    Perez-Matute, Patricia
    Recio-Fernandez, Emma
    Iniguez, Maria
    Blanco-Navarrete, Pilar
    Metola, Luis
    Ibarra, Valvanera
    Alba, Jorge
    de Toro, Maria
    Oteo, Jose A.
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [33] Pharmacokinetics of HIV-Integrase Inhibitors During Pregnancy: Mechanisms, Clinical Implications and Knowledge Gaps
    van der Galien, Ruben
    ter Heine, Rob
    Greupink, Rick
    Schalkwijk, Stein J.
    van Herwaarden, Antonius E.
    Colbers, Angela
    Burger, David M.
    CLINICAL PHARMACOKINETICS, 2019, 58 (03) : 309 - 323
  • [34] HIV integrase inhibitors - Out of the pipeline and into the clinic
    Havlir, Diane V.
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (04): : 416 - 418
  • [35] Update on Adverse Effects of HIV Integrase Inhibitors
    Kolakowska, Agnieszka
    Maresca, Anaenza Freire
    Collins, Intira Jeannie
    Cailhol, Johann
    CURRENT TREATMENT OPTIONS IN INFECTIOUS DISEASES, 2019, 11 (04) : 372 - 387
  • [36] Probing chelation motifs in HIV integrase inhibitors
    Agrawal, Arpita
    DeSoto, Jamie
    Fullagar, Jessica L.
    Maddali, Kasthuraiah
    Rostami, Shahrzad
    Richman, Douglas D.
    Pommier, Yves
    Cohen, Seth M.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (07) : 2251 - 2256
  • [37] HIV Drug Resistance and the Advent of Integrase Inhibitors
    Peter K. Quashie
    Thibault Mesplède
    Mark A. Wainberg
    Current Infectious Disease Reports, 2013, 15 : 85 - 100
  • [38] DOLUTEGRAVIR HIV Integrase Inhibitor Treatment of HIV Infection
    Wainberg, Mark A.
    Quashie, Peter K.
    Mesplede, Thibault
    DRUGS OF THE FUTURE, 2012, 37 (10) : 697 - 707
  • [39] DOLUTEGRAVIR, AN HIV INTEGRASE INHIBITOR FOR THE TREATMENT OF HIV INFECTION
    Temesgen, Z.
    Talwani, R.
    Rizza, S. A.
    DRUGS OF TODAY, 2014, 50 (01) : 7 - 14
  • [40] Integrase inhibitors against HIV: efficacy and resistance
    Tau, Pamela
    Rusconi, Stefano
    FUTURE VIROLOGY, 2016, 11 (02) : 109 - 112
12345